Injectable Lipid-Lowering Therapies
Cardiovascular disease (CVD) remains a leading cause of death globally, with elevated lipid levels being a significant risk factor. Traditionally, lipid-lowering therapies, such as statins, have been the cornerstone of managing dyslipidemia. However, not all patients achieve optimal lipid levels with these treatments, and some may experience side effects. In recent years, injectable lipid-lowering therapies have emerged as an effective alternative or adjunct to oral medications, offering new hope for patients struggling to control their cholesterol levels. This article explores the various types of injectable lipid-lowering therapies, their mechanisms of action, clinical benefits, and potential future developments. Types of Injectable Lipid-Lowering Therapies 1. PCSK9 Inhibitors Mechanism of Action Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors work by targeting PCSK9, a protein that degrades low-density lipoprotein receptors (LDLR) on liver cells. By inhibiting PCSK9...